tiprankstipranks
Trending News
More News >
LianBio Sponsored ADR (LIANY)
OTHER OTC:LIANY
US Market
Advertisement

LianBio Sponsored ADR (LIANY) Stock Statistics & Valuation Metrics

Compare
64 Followers

Total Valuation

LianBio Sponsored ADR has a market cap or net worth of $6.55M. The enterprise value is ―.
Market Cap$6.55M
Enterprise Value

Share Statistics

LianBio Sponsored ADR has 108,062,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding108,062,640
Owned by Insiders
Owned by Institutions

Financial Efficiency

LianBio Sponsored ADR’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -62.37%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)-62.37%
Return on Capital Employed (ROCE)-0.62
Revenue Per Employee0.00
Profits Per Employee15.19K
Employee Count163
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of LianBio Sponsored ADR is 0.1. LianBio Sponsored ADR’s PEG ratio is -0.12.
PE Ratio0.1
PS Ratio0.00
PB Ratio0.46
Price to Fair Value0.46
Price to FCF7.66
Price to Operating Cash Flow0.02
PEG Ratio-0.12

Income Statement

In the last 12 months, LianBio Sponsored ADR had revenue of 0.00 and earned 2.48M in profits. Earnings per share was 0.02.
Revenue0.00
Gross Profit-801.40K
Operating Income-38.86M
Pretax Income2.45M
Net Income2.48M
EBITDA3.26M
Earnings Per Share (EPS)0.02

Cash Flow

In the last 12 months, operating cash flow was 258.94M and capital expenditures -374.67K, giving a free cash flow of 258.56M billion.
Operating Cash Flow258.94M
Free Cash Flow258.56M
Free Cash Flow per Share2.39

Dividends & Yields

LianBio Sponsored ADR pays an annual dividend of $0.43, resulting in a dividend yield of ―
Dividend Per Share$0.43
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.15
52-Week Price Change100.00%
50-Day Moving Average0.06
200-Day Moving Average0.04
Relative Strength Index (RSI)51.36
Average Volume (3m)126.62K

Important Dates

LianBio Sponsored ADR upcoming earnings date is Dec 5, 2024, After Close (Confirmed).
Last Earnings DateAug 8, 2024
Next Earnings DateDec 5, 2024
Ex-Dividend DateJul 15, 2025

Financial Position

LianBio Sponsored ADR as a current ratio of 74.19, with Debt / Equity ratio of 0.42%
Current Ratio74.19
Quick Ratio74.19
Debt to Market Cap0.00
Net Debt to EBITDA-15.88
Interest Coverage Ratio0.00

Taxes

In the past 12 months, LianBio Sponsored ADR has paid -22.01K in taxes.
Income Tax-22.01K
Effective Tax Rate>-0.01

Enterprise Valuation

LianBio Sponsored ADR EV to EBITDA ratio is -7.07, with an EV/FCF ratio of -6.14.
EV to Sales0.00
EV to EBITDA-7.07
EV to Free Cash Flow-6.14
EV to Operating Cash Flow-6.14

Balance Sheet

LianBio Sponsored ADR has $567.37M in cash and marketable securities with $2.46M in debt, giving a net cash position of $564.92M billion.
Cash & Marketable Securities$567.37M
Total Debt$2.46M
Net Cash$564.92M
Net Cash Per Share$5.23
Tangible Book Value Per Share$0.58

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for LianBio Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score5
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis